Worldwide Acute Coronary Syndrome Market 2018: A cardiac conundrum in middle aged people Industry forecast by key players Boehringer Ingelheim International GmbH, Johnson & Johnson Services, Inc., Amgen Inc., Bayer AG, GlaxoSmithKline Plc., Merck & Co., I

Acute Coronary Syndrome Market 2018 is latest market research report published by “Market Research Future”, which includes comprehensive information on Global Acute Coronary Syndrome Market with historic and forecast data on Acute Coronary Syndrome Industry Size, Share, Growth, Trends, And Key Company Analysis with Regional Outlook To 2023. Global Acute Coronary Syndrome Market growing at CAGR of Over 10.4% from 2018 to 2023.

Global Acute Coronary Syndrome Market Research Report by Type (Unstable Angina, Nstemi), by Diagnosis (Blood Tests, Imaging, Stress Test), Treatment (Medication, Surgery), End-User (Hospitals & Clinics, Diagnostic Centers).

Key Companies Analyzed In Report Are:

The key players for the global acute coronary syndrome market are Boehringer Ingelheim International GmbH (Germany), Johnson & Johnson Services, Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Portola Pharmaceuticals, Inc. (U.S.), AbbVie Inc. (U.S.), AstraZeneca (U.K), Amgen Inc. (U.S.), Bayer AG (Germany), DAIICHI SANKYO COMPANY, LIMITED. (Japan), Eli Lilly and Company (U.S.), GlaxoSmithKline Plc. (U.K), Sanofi (Paris), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), and others.

Get Sample Copy of Report At: https://www.marketresearchfuture.com/sample_request/5782

Market Drivers and Restraints:

The acute coronary syndrome is a medical condition characterized by a sudden slowing or blockage of blood supply to the heart. The acute coronary syndrome can be exampled by myocardial infarction. Indigestion, dyspnea, diaphoresis, and unexplained fatigue are some of the common symptoms associated with the syndrome. The increasing prevalence of coronary heart disease and growing geriatric population is expected to be a major driver for the market growth during the forecast period. According to the Centers for Disease Control and Prevention in 2017, approximately 366,000 people died due to coronary heart disease within the Americas in 2015. Moreover, according to the World Health Organization, people who age 65 years or more are projected to grow from 524 million in 2010 to nearly 1.5 billion by 2050. Additionally, factors such as rising prevalence of diabetes and growing obese population boost the market growth. However, lack of awareness, high therapeutic surgery cost, and low per capita healthcare expenditure in the middle and low-income countries are estimated to restrain the market growth during the forecast period. As per a study published in the Brazilian Journal of Cardiovascular Surgery, the average cost for coronary artery bypass graft surgery, per patient, was estimated to be about USD 7,992.55 in 2017.
Global Acute Coronary Syndrome is expected to grow at an approximate CAGR of 10.4% during the forecast period.

Market Segmentation:

The global acute coronary syndrome market is segmented on the basis of type, diagnosis, treatment, and end-user.

On the basis of type, the market is segmented into unstable angina, ST-Elevation Myocardial Infarction (STEMI), Non-ST-Elevation Myocardial Infarction (NSTEMI), and others. On the basis of diagnosis, the market is categorized into blood tests, imaging, stress test, and others. The imaging segment is sub-segmented into Myocardial Perfusion Imaging (MPI), Computerized Tomography (CT) angiogram, echocardiogram, coronary angiogram, and others. On the basis of treatment, the market is segmented into medication, surgery, and others. The medication segment is sub-segmented into thrombolytics, nitroglycerin, antiplatelet drugs, beta blockers, statins, surgery, and others. The antiplatelet drugs segment is further segmented into aspirin, clopidogrel, prasugrel, and others. The beta blockers segment is further segmented into metoprolol, nadolol, and others. The statins segment is further segment into atorvastatin, simvastatin, and others. The surgery segment is sub-segmented into angioplasty and stenting, coronary bypass surgery, and others. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, academic institutes, and others.

Make an Inquire before Buying at https://www.marketresearchfuture.com/enquiry/5782

Detailed Regional Analysis:

The Americas dominates the global acute coronary syndrome market. Factors such as the rising prevalence of coronary heart disease and presence of a well-developed healthcare sector within the region are expected to drive the market growth during the forecast period. Moreover, the increasing healthcare expenditure and presence of market players such as AbbVie Inc., Amgen Inc, Johnson & Johnson Services, Inc., and others within the regional boundaries boost the market growth. Europe stands second in the global acute coronary syndrome market. This can be attributed to the increasing availability of funds for research, a huge patient population, and a well-developed healthcare sector within Europe. Moreover, growing geriatric and obese population boosts the market growth.

Followed by Europe, Asia Pacific is estimated to be the fastest growing region. The presence of developing economies, huge patient population, rising healthcare expenditure, and a rapidly developing healthcare sector drive the market growth within the region. On the other hand, the Middle East and Africa has the least share in the global acute coronary syndrome market due to the low per capita healthcare expenditure and stringent government policies, especially within the African region. It is estimated that the Middle East holds a majority of the market within the Middle Eastern and African region.

List of Tables:

Table 1 Acute Coronary Syndrome Industry Synopsis, 2017–2023
Table 2 Global Acute Coronary Syndrome Market Estimates & Forecast, 2017–2023, (USD Million)
Table 3 Global Acute Coronary Syndrome Market, By Region, 2017–2023, (USD Million)
Table 4 Global Acute Coronary Syndrome Market, By Type, 2017–2023, (USD Million)
Table 5 Global Acute Coronary Syndrome Market, By Diagnosis, 2017–2023, (USD Million)
Table 6 Global Acute Coronary Syndrome Market, By Treatment, 2017–2023, (USD Million)
Table 7 Global Acute Coronary Syndrome Market, By End-User, 2017–2023, (USD Million
Table 8 North America Acute Coronary Syndrome Market, By Type, 2017–2023, (USD Million)
Table 9 North America Acute Coronary Syndrome Market, By Diagnosis, 2017–2023, (USD Million)
Table 10 North America Acute Coronary Syndrome Market, By Treatment, 2017–2023, (USD Million)

List of Figures:

Figure 1 Research Process
Figure 2 Segmentation For Global Acute Coronary Syndrome Market
Figure 3 Market Dynamics For Global Acute Coronary Syndrome Market
Figure 4 Global Acute Coronary Syndrome Market Share, By Type, 2016
Figure 5 Global Acute Coronary Syndrome Market Share, By Diagnosis, 2016
Figure 6 Global Acute Coronary Syndrome Market Share, By Treatment, 2016
Figure 7 Global Acute Coronary Syndrome Market Share, By End-User, 2016
Figure 8 Global Acute Coronary Syndrome Market Share, By Region, 2016
Figure 9 North America Acute Coronary Syndrome Market Share, By Country, 2016
Figure 10 Europe Acute Coronary Syndrome Market Share, By Country, 2016

Browse more on “Acute Coronary Syndrome Market Research Report- Forecast 2023” at: https://www.marketresearchfuture.com/reports/acute-coronary-syndrome-market-5782

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.